---
document_datetime: 2025-12-11 15:58:52
document_pages: 4
document_pathfilename: www.ema.europa.eu/en/documents/procedural-steps-after/darunavir-viatris-previously-darunavir-mylan-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf
document_name: darunavir-viatris-previously-darunavir-mylan-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf
version: success
processing_time: 2.4952312
conversion_datetime: 2025-12-28 03:03:17.641073
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
## Darunavir Viatris

Procedural steps taken and scientific information after the authorisation*

*Due to the Agency`s update of its procedure management systems, an additional document, reflecting the historical lifecycle may be available in the 'Assessment history' section. For the complete product lifecycle procedures, you may need to also refer to EPAR - Procedural steps taken and scientific information after authorisation (archive) .

| Application number   | Scope                                        | Opinion/ Notification 1 issued on   | Commission Decision Issued 2 / amended on   | Product Information affected 3   | Summary   |
|----------------------|----------------------------------------------|-------------------------------------|---------------------------------------------|----------------------------------|-----------|
| Article 61(3) /      | - Notification acc. Article 61(3) - Accepted | 04/12/2025                          |                                             | PL                               |           |

<!-- image -->

<!-- image -->

<div style=\"page-break-after: always\"></div>

| EMA/N/0000315580                      | Update of the package leaflet with revised contact details of local representative and deletion of 'United Kingdom (Northern Ireland)' from the list of local representatives in line with the QRD template v10.4.                                                                                                                                                                                                                                                                                                      |            |     |
|---------------------------------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|-----|
| Variation type IB / EMA/VR/0000286659 | B.II.e) Container closure system - B.II.e.z Other variation - Accepted                                                                                                                                                                                                                                                                                                                                                                                                                                                  | 31/07/2025 | N/A |
| Variation type IB / EMA/VR/0000274724 | This was an application for a group of variations. B.II.e.2 Change in the specification parameters and/or limits of the immediate packaging of the finished product - B.II.e.2.z Other changes - Accepted B.II.e.2 Change in the specification parameters and/or limits of the immediate packaging of the finished product - B.II.e.2.z Other changes - Accepted B.II.e.2 Change in the specification parameters and/or limits of the immediate packaging of the finished product - B.II.e.2.z Other changes - Accepted | 21/07/2025 | N/A |

<div style=\"page-break-after: always\"></div>

| Variation type IA / EMA/VR/0000280786                   | A. ADMINISTRATIVE CHANGES - A.4 Change in the name and/or address of: a manufacturer (including where relevant quality control testing sites); or an ASMF holder; or a supplier of the active substance, starting material, reagent or intermediate used in the manufacture of the active substance (where specified in the technical dossier) where no Ph. Eur. Certificate of Suitability is part of the approved dossier; or a manufacturer of a novel excipient (where specified in the technical dossier) - Accepted   | 24/06/2025   | N/A        |                        |                   |
|---------------------------------------------------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|------------|------------------------|-------------------|
| Variation type IB / EMA/VR/0000254721                   | B.II. FINISHED PRODUCT - B.II.z Other variation - Accepted                                                                                                                                                                                                                                                                                                                                                                                                                                                                  | 18/03/2025   | N/A        |                        |                   |
| Variation type IA_IN / EMA/VR/0000230157                | B.II.b.1 Replacement or addition of a manufacturing site for part or all of the manufacturing process of the finished product - B.II.b.1.a Secondary packaging site - Accepted                                                                                                                                                                                                                                                                                                                                              | 03/10/2024   | N/A        |                        |                   |
| Marketing Authorisation Transfer - H / EMA/T/0000178554 | - Transfer of a marketing authorisation - Transfer of Marketing Authorisation from Mylan Pharmaceuticals Limited to Viatris Limited.                                                                                                                                                                                                                                                                                                                                                                                        | 31/05/2024   | 05/07/2024 | SmPC, Labelling and PL |                   |
| Variation type IA_IN /                                  | A.2 Change in the (invented) name of the medicinal product - A.2.a) for Centrally Authorised products - Accepted                                                                                                                                                                                                                                                                                                                                                                                                            | 18/04/2024   | 13/06/2024 | SmPC, Labelling and    | EMA/VR/0000174634 |

<div style=\"page-break-after: always\"></div>

| PL   |
|------|